Connect
MJA
MJA

News briefs

Cate Swannell
Med J Aust 2018; 209 (7): . || doi: 10.5694/mja18.n0110
Published online: 1 October 2018

Routine testing for prostate cancer is not recommended for most men because the benefit is small and uncertain, and there are clear harms, according to a panel of international experts in The BMJ. But they acknowledge that some men, such as those with a family history of prostate cancer, may be more likely to consider screening, and for this group, discussing possible harms and benefits with their doctor is essential. An international panel including clinicians, men at risk of prostate cancer, and research methodologists undertook a detailed analysis of the latest evidence, applying the GRADE system for assessing its quality. A review including more than 700 000 men in clinical trials found that the benefit of screening for reducing prostate cancer-related deaths is at best very small. Accordingly, the panel advised against offering routine prostate-specific antigen (PSA) screening, noting that most men decline screening because the benefits are small and uncertain and the harms are clear. Clinicians need not feel obliged to systematically raise the question with all their patients, and should engage in shared decision-making for those considering screening. A linked editorial pointed to recent advances in active surveillance, “which have the potential to reduce the harms of testing”. In the meantime, the experts suggest that conversations with patients requesting a PSA test “should explore their reasons for requesting a test, and include evidence-based discussions about possible harms and benefits of PSA testing, informed by the patient’s ethnicity and family history”.

  • Cate Swannell


Correspondence: 

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.